Developer of cancer diagnostics and gene discovery technology. The company offers a technology to measure circulating tumor cells (CTCs) in cancer patients in order to develop non-invasive diagnostic testing.
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
2. Seed Round | 02-Dec-2015 | $2M | 000 | Completed | Startup | |
1. Accelerator/Incubator | Completed | Startup |
Name | Title | Board Seat | Contact Info |
---|---|---|---|
Jeffrey Janco | Executive Vice President, Board Member & Chief Operating Officer |
Growth Rate
Size Multiple
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialInvestor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|---|---|---|---|---|
Oncolys BioPharma | Corporation | Minority | 000 0000 | 000000 0 | |
UPstart (Philadelphia) | Accelerator/Incubator | 000 0000 | 000000 0 |